世界の慢性骨髄性白血病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Myelogenous Leukemia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1322 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、慢性骨髄性白血病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（疾患特異的治療、対症療法）、用途別市場規模（病院薬局、専門薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・慢性骨髄性白血病治療の市場動向 ・企業の競争状況、市場シェア ・慢性骨髄性白血病治療の種類別市場規模（疾患特異的治療、対症療法） ・慢性骨髄性白血病治療の用途別市場規模（病院薬局、専門薬局、小売薬局） ・慢性骨髄性白血病治療の北米市場規模2016-2027（アメリカ、カナダ） ・慢性骨髄性白血病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性骨髄性白血病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性骨髄性白血病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性骨髄性白血病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、Novartis、Pfizer、Teva Pharmaceuticals、Roche、Incyte、Bio-Path Holdings） ・結論

Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It’s a type of cancer that starts in certain blood-forming cells of the bone marrow.

Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market
The global Chronic Myelogenous Leukemia Treatment market size is projected to reach US$ 5799.3 million by 2026, from US$ 4453.9 million in 2019, at a CAGR of 3.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Myelogenous Leukemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Myelogenous Leukemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Myelogenous Leukemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Myelogenous Leukemia Treatment market.

Global Chronic Myelogenous Leukemia Treatment Scope and Market Size
Chronic Myelogenous Leukemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Myelogenous Leukemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Disease Specific Treatment
Symptomatic Treatment

Segment by Application
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol-Myers Squibb
Novartis
Pfizer
Teva Pharmaceuticals
Roche
Incyte
Bio-Path Holdings

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Myelogenous Leukemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Disease Specific Treatment
1.2.3 Symptomatic Treatment
1.3 Market by Application
1.3.1 Global Chronic Myelogenous Leukemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Specialty Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Myelogenous Leukemia Treatment Market Perspective (2016-2027)
2.2 Chronic Myelogenous Leukemia Treatment Growth Trends by Regions
2.2.1 Chronic Myelogenous Leukemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Myelogenous Leukemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Myelogenous Leukemia Treatment Industry Dynamic
2.3.1 Chronic Myelogenous Leukemia Treatment Market Trends
2.3.2 Chronic Myelogenous Leukemia Treatment Market Drivers
2.3.3 Chronic Myelogenous Leukemia Treatment Market Challenges
2.3.4 Chronic Myelogenous Leukemia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Myelogenous Leukemia Treatment Players by Revenue
3.1.1 Global Top Chronic Myelogenous Leukemia Treatment Players by Revenue (2016-2021)
3.1.2 Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Myelogenous Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Myelogenous Leukemia Treatment Revenue
3.4 Global Chronic Myelogenous Leukemia Treatment Market Concentration Ratio
3.4.1 Global Chronic Myelogenous Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Myelogenous Leukemia Treatment Revenue in 2020
3.5 Chronic Myelogenous Leukemia Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Myelogenous Leukemia Treatment Product Solution and Service
3.7 Date of Enter into Chronic Myelogenous Leukemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Myelogenous Leukemia Treatment Breakdown Data by Type
4.1 Global Chronic Myelogenous Leukemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Type (2022-2027)

5 Chronic Myelogenous Leukemia Treatment Breakdown Data by Application
5.1 Global Chronic Myelogenous Leukemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Myelogenous Leukemia Treatment Market Size (2016-2027)
6.2 North America Chronic Myelogenous Leukemia Treatment Market Size by Type
6.2.1 North America Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021)
6.2.2 North America Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027)
6.2.3 North America Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2027)
6.3 North America Chronic Myelogenous Leukemia Treatment Market Size by Application
6.3.1 North America Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021)
6.3.2 North America Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027)
6.3.3 North America Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2027)
6.4 North America Chronic Myelogenous Leukemia Treatment Market Size by Country
6.4.1 North America Chronic Myelogenous Leukemia Treatment Market Size by Country (2016-2021)
6.4.2 North America Chronic Myelogenous Leukemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Chronic Myelogenous Leukemia Treatment Market Size (2016-2027)
7.2 Europe Chronic Myelogenous Leukemia Treatment Market Size by Type
7.2.1 Europe Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2027)
7.3 Europe Chronic Myelogenous Leukemia Treatment Market Size by Application
7.3.1 Europe Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2027)
7.4 Europe Chronic Myelogenous Leukemia Treatment Market Size by Country
7.4.1 Europe Chronic Myelogenous Leukemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chronic Myelogenous Leukemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Myelogenous Leukemia Treatment Market Size (2016-2027)
9.2 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Type
9.2.1 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2027)
9.3 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Application
9.3.1 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2027)
9.4 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Country
9.4.1 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Myelogenous Leukemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Chronic Myelogenous Leukemia Treatment Introduction
11.1.4 Bristol-Myers Squibb Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Chronic Myelogenous Leukemia Treatment Introduction
11.2.4 Novartis Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Chronic Myelogenous Leukemia Treatment Introduction
11.3.4 Pfizer Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Details
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Chronic Myelogenous Leukemia Treatment Introduction
11.4.4 Teva Pharmaceuticals Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Chronic Myelogenous Leukemia Treatment Introduction
11.5.4 Roche Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Incyte
11.6.1 Incyte Company Details
11.6.2 Incyte Business Overview
11.6.3 Incyte Chronic Myelogenous Leukemia Treatment Introduction
11.6.4 Incyte Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
11.6.5 Incyte Recent Development
11.7 Bio-Path Holdings
11.7.1 Bio-Path Holdings Company Details
11.7.2 Bio-Path Holdings Business Overview
11.7.3 Bio-Path Holdings Chronic Myelogenous Leukemia Treatment Introduction
11.7.4 Bio-Path Holdings Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
11.7.5 Bio-Path Holdings Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Myelogenous Leukemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Disease Specific Treatment
Table 3. Key Players of Symptomatic Treatment
Table 4. Global Chronic Myelogenous Leukemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Chronic Myelogenous Leukemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Myelogenous Leukemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Chronic Myelogenous Leukemia Treatment Market Share by Regions (2016-2021)
Table 8. Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Chronic Myelogenous Leukemia Treatment Market Share by Regions (2022-2027)
Table 10. Chronic Myelogenous Leukemia Treatment Market Trends
Table 11. Chronic Myelogenous Leukemia Treatment Market Drivers
Table 12. Chronic Myelogenous Leukemia Treatment Market Challenges
Table 13. Chronic Myelogenous Leukemia Treatment Market Restraints
Table 14. Global Chronic Myelogenous Leukemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Chronic Myelogenous Leukemia Treatment Market Share by Players (2016-2021)
Table 16. Global Top Chronic Myelogenous Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myelogenous Leukemia Treatment as of 2020)
Table 17. Ranking of Global Top Chronic Myelogenous Leukemia Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Chronic Myelogenous Leukemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chronic Myelogenous Leukemia Treatment Product Solution and Service
Table 21. Date of Enter into Chronic Myelogenous Leukemia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Chronic Myelogenous Leukemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Chronic Myelogenous Leukemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Chronic Myelogenous Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Chronic Myelogenous Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Chronic Myelogenous Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Chronic Myelogenous Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Chronic Myelogenous Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Chronic Myelogenous Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bristol-Myers Squibb Company Details
Table 62. Bristol-Myers Squibb Business Overview
Table 63. Bristol-Myers Squibb Chronic Myelogenous Leukemia Treatment Product
Table 64. Bristol-Myers Squibb Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 65. Bristol-Myers Squibb Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Chronic Myelogenous Leukemia Treatment Product
Table 69. Novartis Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Chronic Myelogenous Leukemia Treatment Product
Table 74. Pfizer Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Teva Pharmaceuticals Company Details
Table 77. Teva Pharmaceuticals Business Overview
Table 78. Teva Pharmaceuticals Chronic Myelogenous Leukemia Treatment Product
Table 79. Teva Pharmaceuticals Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceuticals Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Chronic Myelogenous Leukemia Treatment Product
Table 84. Roche Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 85. Roche Recent Development
Table 86. Incyte Company Details
Table 87. Incyte Business Overview
Table 88. Incyte Chronic Myelogenous Leukemia Treatment Product
Table 89. Incyte Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 90. Incyte Recent Development
Table 91. Bio-Path Holdings Company Details
Table 92. Bio-Path Holdings Business Overview
Table 93. Bio-Path Holdings Chronic Myelogenous Leukemia Treatment Product
Table 94. Bio-Path Holdings Revenue in Chronic Myelogenous Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 95. Bio-Path Holdings Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Myelogenous Leukemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Disease Specific Treatment Features
Figure 3. Symptomatic Treatment Features
Figure 4. Global Chronic Myelogenous Leukemia Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Specialty Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Chronic Myelogenous Leukemia Treatment Report Years Considered
Figure 9. Global Chronic Myelogenous Leukemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Chronic Myelogenous Leukemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Chronic Myelogenous Leukemia Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Chronic Myelogenous Leukemia Treatment Market Share by Regions (2022-2027)
Figure 13. Global Chronic Myelogenous Leukemia Treatment Market Share by Players in 2020
Figure 14. Global Top Chronic Myelogenous Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myelogenous Leukemia Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Chronic Myelogenous Leukemia Treatment Revenue in 2020
Figure 16. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Chronic Myelogenous Leukemia Treatment Market Share by Type (2016-2027)
Figure 20. North America Chronic Myelogenous Leukemia Treatment Market Share by Application (2016-2027)
Figure 21. North America Chronic Myelogenous Leukemia Treatment Market Share by Country (2016-2027)
Figure 22. United States Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Myelogenous Leukemia Treatment Market Share by Type (2016-2027)
Figure 26. Europe Chronic Myelogenous Leukemia Treatment Market Share by Application (2016-2027)
Figure 27. Europe Chronic Myelogenous Leukemia Treatment Market Share by Country (2016-2027)
Figure 28. Germany Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Chronic Myelogenous Leukemia Treatment Market Share by Region (2016-2027)
Figure 38. China Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Myelogenous Leukemia Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Chronic Myelogenous Leukemia Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Chronic Myelogenous Leukemia Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Chronic Myelogenous Leukemia Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Chronic Myelogenous Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
Figure 60. Teva Pharmaceuticals Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
Figure 62. Incyte Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
Figure 63. Bio-Path Holdings Revenue Growth Rate in Chronic Myelogenous Leukemia Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---